Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
CNY 30.51
(-0.46%)
CNY 30.51
(-0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 21.15 Billion | 18.91 Billion | 17.27 Billion | 16.46 Billion | 17.63 Billion | 16.35 Billion |
| Cost of Revenue | 10.44 Billion | 8.95 Billion | 7.66 Billion | 7.53 Billion | 7.02 Billion | 6.61 Billion |
| Gross Profit | 10.7 Billion | 9.95 Billion | 9.61 Billion | 8.93 Billion | 10.61 Billion | 9.73 Billion |
| Operating Expenses | 7.5 Billion | 7.41 Billion | 7.9 Billion | 7.29 Billion | 8.8 Billion | 7.77 Billion |
| Selling, General and Administrative Expenses | 5.62 Billion | 4.99 Billion | 5.34 Billion | 5.17 Billion | 6.76 Billion | 6.14 Billion |
| Research and Development Expenses | 1.94 Billion | 1.79 Billion | 1.73 Billion | 1.52 Billion | 1.28 Billion | 885.23 Million |
| Other Expenses | -65.89 Million | 626.89 Million | 829.69 Million | 590.59 Million | 753.47 Million | -22.79 Million |
| Cost and Expenses | 17.79 Billion | 16.37 Billion | 15.56 Billion | 14.82 Billion | 15.82 Billion | 14.38 Billion |
| Operating Income | 3.65 Billion | 2.19 Billion | 1.79 Billion | 1.63 Billion | 1.97 Billion | 1.35 Billion |
| Interest Expense | 370.7 Million | 473.7 Million | 518.33 Million | 554.85 Million | 584.82 Million | 613.84 Million |
| Income Tax Expense | 933.78 Million | 364 Million | 309.49 Million | 163.55 Million | 234.75 Million | 65.92 Million |
| Earnings before Tax | 3.58 Billion | 2.07 Billion | 1.17 Billion | 955.03 Million | 1.25 Billion | 1.33 Billion |
| Net Income | 2.45 Billion | 1.7 Billion | 868.11 Million | 829.38 Million | 937.85 Million | 1.21 Billion |
| Earnings Per Share Basic | 1.69 | 1.22 | 0.61 | 0.58 | 0.66 | 0.85 |
| Earnings Per Share Diluted | 1.59 | 1.15 | 0.61 | 0.58 | 0.66 | 0.85 |
| Weighted Average Shares Outstanding | 1.45 Billion | 1.4 Billion | 1.41 Billion | 1.42 Billion | 1.42 Billion | 1.42 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.54 Billion | 1.48 Billion | 1.41 Billion | 1.42 Billion | 1.42 Billion | 1.42 Billion |
| Gross Margin | 0.51 | 0.53 | 0.56 | 0.54 | 0.60 | 0.60 |
| EBIT Margin | 0.23 | 0.20 | 0.17 | 0.17 | 0.17 | 0.19 |
| Profit Margin | 0.12 | 0.09 | 0.05 | 0.05 | 0.05 | 0.07 |
| EBITDA | 4.85 Billion | 3.51 Billion | 2.8 Billion | 2.6 Billion | 2.76 Billion | 2.8 Billion |
| Earnings Before Tax Margin | 0.17 | 0.12 | 0.10 | 0.10 | 0.11 | 0.08 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 4.88 Billion | 5.6 Billion | 6.15 Billion | 21.15 Billion | 5.64 Billion | 5 Billion |
| Cost of Revenue | 2.51 Billion | 2.71 Billion | 2.74 Billion | 10.44 Billion | 2.84 Billion | 2.39 Billion |
| Gross Profit | 2.37 Billion | 2.89 Billion | 3.4 Billion | 10.7 Billion | 2.79 Billion | 2.61 Billion |
| Operating Expenses | 1.57 Billion | 4.32 Billion | 1.98 Billion | 7.42 Billion | 1.91 Billion | 1.9 Billion |
| Selling, General and Administrative Expenses | 1.06 Billion | 663.07 Million | 1.48 Billion | - | 1.57 Billion | 1.63 Billion |
| Research and Development Expenses | 506.01 Million | 575.3 Million | 502.81 Million | - | 249.87 Million | 589.8 Million |
| Other Expenses | -4.45 Million | -4.32 Billion | -7.65 Million | -85.43 Million | -83.95 Million | -23.06 Million |
| Cost and Expenses | 4.09 Billion | 4.32 Billion | 4.73 Billion | 17.87 Billion | 4.76 Billion | 4.3 Billion |
| Operating Income | 797.78 Million | 1.27 Billion | 1.42 Billion | 3.27 Billion | 878.77 Million | 719.91 Million |
| Interest Expense | 34.08 Million | 41.87 Million | 47.63 Million | 361.53 Million | 70.34 Million | 61.33 Million |
| Income Tax Expense | 135.36 Million | 725.96 Million | 338.99 Million | 933.78 Million | 531.02 Million | 127.22 Million |
| Earnings before Tax | 776.06 Million | 1.24 Billion | 1.51 Billion | 3.22 Billion | 941.87 Million | 692.6 Million |
| Net Income | 670.81 Million | 514.3 Million | 1.02 Billion | 2.45 Billion | 492.78 Million | 561.12 Million |
| Earnings Per Share Basic | 0.42 | 0.32 | 0.67 | - | 0.33 | 0.38 |
| Earnings Per Share Diluted | 0.42 | 0.32 | 0.67 | - | 0.32 | 0.36 |
| Weighted Average Shares Outstanding | 1.6 Billion | 1.59 Billion | 1.53 Billion | 1.45 Billion | 1.49 Billion | 1.47 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.6 Billion | 1.59 Billion | 1.53 Billion | 1.54 Billion | 1.53 Billion | 1.55 Billion |
| Gross Margin | 0.49 | 0.52 | 0.55 | 0.51 | 0.49 | 0.52 |
| EBIT Margin | 0.17 | 0.23 | 0.28 | - | 0.21 | 0.16 |
| Profit Margin | 0.14 | 0.09 | 0.17 | 0.12 | 0.09 | 0.11 |
| EBITDA | 810.14 Million | 1.27 Billion | 1.71 Billion | - | 1.19 Billion | 801.53 Million |
| Earnings Before Tax Margin | 0.16 | 0.23 | 0.23 | 0.16 | 0.16 | 0.14 |
OVS
PORF
ALFLO
CART
004060
TREL